NewsRoom Articles - Page 951 of 1466

MondayMar 18, 2019 1:30 pm

Altimmune Inc. (NASDAQ: ALT) Attends 31st Annual ROTH Conference

Altimmune (NASDAQ: ALT) is a clinical-stage immunotherapeutics company focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. The company strategically employs two distinct and complementary immune platform technologies to create innovative candidates for important diseases. By leveraging the complementary attributes of its proprietary technology platforms, Altimmune is able to design and develop immunotherapeutic products tailored to address a wide range of disease indications including both acute and chronic infections and cancer. For more information, visit the company's website at www.altimmune.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and…

MondayMar 18, 2019 1:00 pm

Allied Motion Technologies Inc. (AMOT) Attends 31st Annual ROTH Conference

Allied Motion Technologies (NASDAQ: AMOT) designs, manufactures and sells precision and specialty motion control components and systems used in a broad range of industries within major markets, including vehicle, medical, aerospace & defense, and industrial. Allied Motion is focused on motion control applications and is known worldwide for its expertise in electro-magnetic, mechanical and electronic motion technology. Its products include brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gear motors, gearing, modular digital servo drives, motion controllers, incremental and absolute optical encoders, and other associated motion control-related products. For more information, visit…

MondayMar 18, 2019 1:00 pm

Allena Pharmaceuticals Inc. (NASDAQ: ALNA) Attends 31st Annual ROTH Conference

Allena Pharmaceuticals (NASDAQ: ALNA) is a late-stage biopharmaceutical company dedicated to developing and commercializing first-in-class oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders. Allena’s lead product candidate, reloxaliase, is a first in class, oral enzyme therapeutic for the treatment of hyperoxaluria, a metabolic disorder characterized by markedly elevated urinary oxalate levels and commonly associated with kidney stones, chronic kidney disease and other serious kidney disorders. For more information, visit the company's website at www.allenapharma.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of…

MondayMar 18, 2019 1:00 pm

Alexco Resource Corp. (NYSE American: AXU) Attends 31st Annual ROTH Conference

Alexco Resource (NYSE American: AXU) owns the majority of the high-grade Keno Hill Silver District in Canada’s Yukon Territory and anticipates the sequential development of four high grade silver deposits over an eight-year mine life producing more than 1 million tons with an average grade of 843 g/t silver, 3.3% lead and 4.6% zinc. Silver production is anticipated to be approximately 3.5 million ounces per year. Mineral resources that are not mineral reserves do not have demonstrated economic viability. Alexco also operates a wholly owned subsidiary, Alexco Environmental Group, that provides mine-related environmental services, remediation technologies and reclamation and mine…

MondayMar 18, 2019 1:00 pm

Aleafia Health Inc. (TSXV: ALEF) (OTCQX: ALEAF) Attends 31st Annual ROTH Conference

Aleafia Health (TSXV: ALEF) (OTCQX: ALEAF) is a vertically integrated, national cannabis health and wellness company with major medical clinic, cannabis cultivation and R&D operations. The company is a federally licensed producer and vendor of cannabis and will reach an annual production capacity of 98,000 kg of dried cannabis in 2019. Aleafia operates medical cannabis clinics staffed by physicians and nurse practitioners, with over 50,000 patients. The company is highly differentiated, maintaining one of the largest medical cannabis datasets in the world. For more information, visit the company's website at www.aleafiainc.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and…

MondayMar 18, 2019 1:00 pm

Inspired Entertainment (NASDAQ: INSE) Attends 31st Annual ROTH Conference

Inspired Entertainment (NASDAQ: INSE) is a global games technology company supplying virtual sports, mobile gaming and server-based gaming systems with associated terminals and digital content to regulated lottery, betting and gaming operators around the world. Inspired currently operates approximately 30,000 digital gaming terminals and supplies its Virtual Sports products through more than 40,000 retail channels and over 100 websites, in approximately 35 gaming jurisdictions worldwide. Inspired employs approximately 800 employees in the UK and elsewhere, developing and operating digital games and networks. For more information, visit the company's website at www.inseinc.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and…

MondayMar 18, 2019 1:00 pm

Insperity Inc. (NYSE: NSP) Attends 31st Annual ROTH Conference

Insperity (NYSE: NSP) provides an array of human resources and business solutions designed to help improve business performance. Insperity Business Performance Advisors offer the most comprehensive suite of products and services available in the marketplace. Insperity delivers administrative relief, better benefits, reduced liabilities and a systematic way to improve productivity through its premier Workforce Optimization solution. Additional company offerings include human capital management, payroll software, time and attendance, performance management, organizational planning, recruiting services, employment screening, financial services, expense management, retirement services and insurance services. For more information, visit the company's website at www.insperity.com. About NetworkNewsWire NetworkNewsWire (NNW) is a…

MondayMar 18, 2019 1:00 pm

Inseego Corp. (NASDAQ: INSG) Attends 31st Annual ROTH Conference

Inseego (NASDAQ: INSG) enables high performance mobile applications for large enterprise verticals, service providers and small-medium businesses around the globe. Inseego’s product portfolio consists of Enterprise SaaS solutions and IoT & Mobile solutions, which together form the backbone of compelling, intelligent, reliable and secure IoT services with deep business intelligence. Inseego powers mission critical applications with a “zero unscheduled downtime” mandate, such as asset tracking, fleet management, industrial IoT, SD WAN failover management and mobile broadband services. The company’s solutions are powered by key innovations in purpose-built SaaS cloud platforms, IoT and mobile technologies including emerging 5G technology. For more…

MondayMar 18, 2019 1:00 pm

Inpixon (NASDAQ: INPX) Attends 31st Annual ROTH Conference

Inpixon (NASDAQ: INPX) is a leader in Indoor Positioning Analytics (IPA). Inpixon IPA Sensors are designed to find all accessible cellular, Wi-Fi, and Bluetooth devices anonymously. Paired with a high-performance data analytics platform, this technology delivers visibility, security and business intelligence on any commercial or government location worldwide. Inpixon’s products and professional services group help customers take advantage of mobile, big data, analytics and the Internet of Things (IoT) to uncover the untold stories of the indoors. For more information, visit the company's website at www.inpixon.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides…

MondayMar 18, 2019 1:00 pm

Inmune Bio Inc. (NASDAQ: INMB) Attends 31st Annual ROTH Conference

Inmune Bio (NASDAQ: INMB) is a clinical-stage biotechnology company developing therapies targeting the innate immune system in cancer. INmune Bio is developing two products platforms that reengineer the patient’s innate immune system’s response to their cancer, INKmune and INB03. INKmune is a Natural Killer (NK) cell therapeutic that primes the patient’s NK cells to attack developing disease. INB03 inhibits myeloid derived suppressor cells (MDSC), which often cause resistance to immunotherapy, such as anti-PD1 checkpoint inhibitors. INmune Bio’s product platforms target residual disease and utilize a precision medicine approach for treatment of a wide variety of hematologic malignancies and solid tumors.…